Aethlon Medical Valuation
| AEMD Stock | USD 0.66 0.29 78.38% |
Aethlon Medical is undervalued. Aethlon Medical shows a prevailing Real Value of $16.7 per share. The current price of the firm is $0.66. Our model approximates the value of Aethlon Medical from analyzing the firm fundamentals such as Return On Equity of -1.05, shares owned by insiders of 0.50 %, and Current Valuation of (954.72 K) as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Aethlon Medical's valuation include:
Price Book 0.8483 | Enterprise Value -954.7 K | Enterprise Value Ebitda 0.2437 | Price Sales 2.3729 | Forward PE 0.2102 |
Undervalued
Today
Please note that Aethlon Medical's price fluctuation is slightly risky at this time. Calculation of the real value of Aethlon Medical is based on 3 months time horizon. Increasing Aethlon Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Aethlon stock is determined by what a typical buyer is willing to pay for full or partial control of Aethlon Medical. Since Aethlon Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aethlon Stock. However, Aethlon Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.66 | Real 16.7 | Target 65.0 | Hype 0.7 |
The real value of Aethlon Stock, also known as its intrinsic value, is the underlying worth of Aethlon Medical Company, which is reflected in its stock price. It is based on Aethlon Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Aethlon Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Aethlon Medical helps investors to forecast how Aethlon stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aethlon Medical more accurately as focusing exclusively on Aethlon Medical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Aethlon Medical's intrinsic value based on its ongoing forecasts of Aethlon Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Aethlon Medical's closest peers. If more than one evaluation category is relevant for Aethlon Medical we suggest using both methods to arrive at a better estimate.
Aethlon Medical Cash |
|
Aethlon Valuation Trend
Comparing Aethlon Medical's enterprise value against its market capitalization is a good way to estimate the value of Aethlon Medical uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Aethlon Medical Total Value Analysis
Aethlon Medical is presently expected to have valuation of (954.72 K) with market capitalization of 9.22 M, debt of 940.32 K, and cash on hands of 14.92 M. The negative valuation of Aethlon Medical may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Aethlon Medical fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(954.72 K) | 9.22 M | 940.32 K | 14.92 M |
Aethlon Medical Asset Utilization
One of the ways to look at asset utilization of Aethlon is to check how much profit was generated for every dollar of assets it reports. Aethlon Medical shows a negative utilization of assets of -0.5 percent, losing $0.005046 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Aethlon Medical shows how discouraging it operates for each dollar spent on its assets.Aethlon Medical Ownership Allocation
Almost 96.41 percent of Aethlon Medical outstanding shares are held by general public with 0.5 (percent) owned by insiders and only 3.09 % by other corporate entities.Aethlon Medical Profitability Analysis
Net Loss for the year was (12.21 M) with profit before overhead, payroll, taxes, and interest of 574.25 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Aethlon Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Aethlon Medical and how it compares across the competition.
About Aethlon Medical Valuation
The stock valuation mechanism determines Aethlon Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Aethlon Medical. We calculate exposure to Aethlon Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aethlon Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -359.1 K | -377 K | |
| Pretax Profit Margin | (18.85) | (19.80) | |
| Operating Profit Margin | (23.83) | (25.02) | |
| Net Loss | (24.09) | (25.30) | |
| Gross Profit Margin | 0.48 | 0.51 |
Aethlon Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Aethlon Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 2.5 M | |
| Forward Price Earnings | 0.2102 |
Aethlon Medical Current Valuation Indicators
Valuation refers to the process of determining the present value of Aethlon Medical and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Aethlon we look at many different elements of the entity such as Aethlon's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Aethlon Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Aethlon Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Aethlon Medical's worth.Complementary Tools for Aethlon Stock analysis
When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |